×

Results hurt by patent expirations: Eli Lilly CEO

7:07 AM ET Thu, 24 July 2014

John Lechleiter, Eli Lilly CEO, breaks down the pharmaceutical giant's quarterly results. And Lechleiter weighs in on the benefits of investing in R&D.